SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-13-009853
Filing Date
2013-02-13
Accepted
2013-02-12 21:56:35
Documents
7
Period of Report
2013-02-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a13-5001_18k.htm 8-K 40528
2 EX-10.1 a13-5001_1ex10d1.htm EX-10.1 162783
3 EX-10.2 a13-5001_1ex10d2.htm EX-10.2 45835
4 EX-10.3 a13-5001_1ex10d3.htm EX-10.3 22008
5 EX-10.4 a13-5001_1ex10d4.htm EX-10.4 22153
6 EX-10.5 a13-5001_1ex10d5.htm EX-10.5 22005
7 EX-10.6 a13-5001_1ex10d6.htm EX-10.6 22005
  Complete submission text file 0001104659-13-009853.txt   338522
Mailing Address 550 HILLS DRIVE BEDMINSTER NJ 07921
Business Address 550 HILLS DRIVE BEDMINSTER NJ 07921 (908) 450-5300
NPS PHARMACEUTICALS INC (Filer) CIK: 0000890465 (see all company filings)

IRS No.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-23272 | Film No.: 13599392
SIC: 2836 Biological Products, (No Diagnostic Substances)